A Diagnostic Feasibility Trial of a [14C]Oxaliplatin Microdosing Assay for Prediction of Chemoresistance to Oxaliplatin Chemotherapy
Phase of Trial: Phase 0
Latest Information Update: 11 Jan 2018
Price : $35 *
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Breast cancer
- Focus Biomarker; Pharmacodynamics
- 04 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 May 2014 New trial record